ClinicalTrials.govpublic full text
ADIponectin and Asymmetric Dimethylarginine (ADMA) Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose Combination
diabetes mellitus, type 2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 435707
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.